NICE to consult on delayed ‘value-based’ drug pricing plans

By Nick Renaud-Komiya2014-03-24T12:13:00

The National Institute for Health and Care Excellence is to announce proposals on Thursday that could see the health service increase the amount it spends on branded pharmaceutical drugs.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters

to HSJ

Already a subscriber? Sign into your account here